An investor asked on the investor interaction platform: Dear secretary, does the company have an export plan for covid-19 drugs?
Shanghai Kaibao Pharmaceutical Co.Ltd(300039) (300039. SZ) said on the investor interaction platform on January 20 that the company pays attention to the development of epidemic situation and is committed to giving full play to the anti epidemic role of products. Due to the different drug policies between foreign countries and China, the company’s main products Tanreqing injection and Tanreqing capsule have not been exported abroad. The company will continue to pay attention to the dynamics of foreign drug laws and regulations and the development of overseas epidemic situations.
